UNSPSC 51112900: Alkylating agent triazines

This classification denotes substances consisting of heterocyclic rings that contain three nitrogen atoms at 1,2,4 or 1,3,5 or 2,4,6, substances called triazines, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term ALKYLATING AGENT TRIAZINES.

UNSPSC 51112900 Alkylating agent triazines is a Class code for chemotherapy drugs in the triazine family, but state and local government procurement activity under this specific code is not evident in recent solicitations. The code nominally describes pharmaceutical active ingredients used in cancer treatment regimens, a category that typically sees procurement through state health departments, correctional systems, and public hospital networks rather than through open competitive bids. However, no recent state or local contract opportunities appear in the available records under this code.

Given the clinical specificity of alkylating agent triazines and their role in specialized oncology settings, procurement patterns likely flow through existing pharmaceutical supply agreements, GPOs (group purchasing organizations), and established institutional formularies rather than through individual solicitations. State and local buyers in this space typically contract for bulk pharmaceutical supplies or work through cooperative purchasing vehicles at the state or regional level, which may not generate discrete public notices under the specific triazine commodity code. If your firm supplies or repackages triazine-based chemotherapy agents, investigate whether opportunities are flowing through your state's health department pharmacy contracts, public teaching hospitals, or prison health services instead of appearing as standalone RFPs or ITBs.